Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stock
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
134.50 | 282 Cr | 33.98 | 5.80 | 0.37 | 13.98 | 18.35 | 9.09 | ||
411.00 | 281 Cr | 99.06 | 2.96 | 0.00 | 3.19 | 5.65 | 1.51 | ||
24.40 | 273 Cr | 23.15 | 2.79 | 0.00 | 10.05 | 14.20 | 5.80 | ||
90.00 | 233 Cr | 177.85 | 4.18 | 0.00 | 4.43 | 8.10 | 1.51 | ||
210.29 | 232 Cr | 57.22 | 6.86 | 0.00 | 7.48 | 7.57 | 9.36 | ||
107.40 | 184 Cr | 23.92 | 2.56 | 0.00 | 39.24 | 24.86 | 0.00 | ||
112.00 | 181 Cr | 11.24 | 1.78 | 0.00 | 14.53 | 9.56 | 6.95 | ||
| Median: 7 Co. | — | 112.00 | 233 Cr | 33.98 | 2.96 | 0.00 | 10.05 | 9.56 | 5.80 |
Arvee Laboratories (India) Ltd (ARVEE) is currently trading at 195.25 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Arvee Laboratories (India) Limited primarily manufactures specialized chemicals for various industrial applications, including Thiophene and Isophthalic acid derivatives. Founded in 2012 and converted into a public company in 2017, Arvee has swiftly established itself as a credible international vendor, having passed rigorous quality audits. The company has strategically expanded its chemical portfolio, emphasizing low wastage and high effectiveness, enhancing its appeal to both domestic and global markets. Arvee's management, led by Mr. Shalin Bharat Chokshi and Mr. Shalin Sudhakarbhai Patel, focuses on innovation and diversification within the specialty chemicals sector.
Over the past 52 weeks, Arvee Laboratories (India) Ltd has traded between a low of ₹129.11 and a high of ₹290.78. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Arvee Laboratories (India) Ltd has a market capitalization of approximately 231.74. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Arvee Laboratories (India) Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 57.22 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 231.74 Cr, Arvee Laboratories (India) Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Arvee Laboratories (India) Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Arvee Laboratories (India) Ltd is 57.22. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Bearish
3
Neutral
6
Bullish
5
Bearish
5
Neutral
6
Bullish
35
Bearish
2
Neutral
0
Bullish
30
Bearish
3
Neutral
6
Bullish
5
Bearish
3
Neutral
6
Bullish
5
Bearish
2
Neutral
0
Bullish
30
Bearish
2
Neutral
0
Bullish
30
Bearish
2
Neutral
0
Bullish
30
Arvee Laboratories (India) Limited primarily manufactures specialized chemicals for various industrial applications, including Thiophene and Isophthalic acid derivatives.
Founded in 2012 and converted into a public company in 2017, Arvee has swiftly established itself as a credible international vendor, having passed rigorous quality audits.
The company has strategically expanded its chemical portfolio, emphasizing low wastage and high effectiveness, enhancing its appeal to both domestic and global markets.
Arvee's management, led by Mr. Shalin Bharat Chokshi and Mr. Shalin Sudhakarbhai Patel, focuses on innovation and diversification within the specialty chemicals sector.
Industrial Products
Other Industrial Products
232 Cr
Moderate Risk
57.2
35.5
0.5
6.9
290.78
129.11
Sales CAGR
Profit CAGR
ROE
ROCE
